Key result
An exercise-induced pulmonary vascular resistance increase >3.5 Wood Units occurred in 48% of HFrEF patients under oral therapy compared to 13% under sodium nitroprusside.
Why the study?
Does sodium nitroprusside compared to oral therapy improve pulmonary vascular response to exercise in symptomatic HFrEF patients with pulmonary hypertension?
Cohort (n=40)
No
Does sodium nitroprusside compared to oral therapy improve pulmonary vascular response to exercise in symptomatic HFrEF patients with pulmonary hypertension?
Absolute Event Rate: 48% vs 13%
In HFrEF patients with pulmonary hypertension, exercise-induced increases in pulmonary vascular resistance impair right ventricular stroke work, which can be ameliorated by nitric oxide donor support.
Nitroprusside was associated with fewer exercise PVR rises in HFrEF-PH; hypothesis-generating, requires randomized trials before practice change.
AIMS: To study pulmonary vascular response patterns to exercise in heart failure with reduced ejection fraction (HFrEF) and pulmonary hypertension (PH). METHODS AND RESULTS: In this prospective single-centre cohort study, consecutive symptomatic HFrEF patients (n = 40) with mean pulmonary arterial pressure (MPAP) ≥25 mmHg, pulmonary artery wedge pressure (PAWP) >15 mmHg, and cardiac index <2.5 L/min.m(2) , received protocol-driven titrated sodium nitroprusside (SNP) and diuretics to reach mean arterial blood pressure 65-75 mmHg and PAWP ≤15 mmHg. Patients performed symptom-limited supine bicycle testing under continued SNP administration. Afterwards, SNP was gradually withdrawn, renin-angiotensin system blockers uptitrated, and hydralazine added to maintain haemodynamic targets. Subsequently, bicycle testing was repeated. Patients presented with pulmonary vascular resistance (PVR) = 3.8 ± 1.4 Wood Units at rest, decreasing to 2.9 ± 0.9 Wood Units after decongestion, with PH was completely reversed (MPAP <25 mmHg) in 22%. From rest to maximal exercise, the cardiac index did not change significantly (P = 0.334 under SNP; P-value = 0.552 under oral therapy). A dynamic exercise-induced PVR increase >3.5 Wood Units was noted in 19 patients (48%) under oral therapy vs. five (13%) under SNP. Such exercise-induced PVR increase was associated with a 33% relative decrease in right ventricular stroke work index (P = 0.037). CONCLUSIONS: Even after thorough decongestion and under continuous afterload reduction, PH secondary to HFrEF is completely reversible in only a minority of patients. Others demonstrate an exercise-induced PVR increase, associated with impaired right ventricular stroke work, which might be ameliorated by nitric oxide donor support.
No takes yet. Share an insight, caveat, or question.
Verbrugge et al. (2014) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) and pulmonary hypertension (PH) (n=40). Oral therapy (renin-angiotensin system blockers and hydralazine) vs. Sodium nitroprusside (SNP) was evaluated on Dynamic exercise-induced pulmonary vascular resistance (PVR) increase >3.5 Wood Units. An exercise-induced pulmonary vascular resistance increase >3.5 Wood Units occurred in 48% of HFrEF patients under oral therapy compared to 13% under sodium nitroprusside.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: